To the despair of some critically ill patients, a federal agency on Friday revoked its approval of Avastin for treating breast cancer after determining the widely used drug developed by South San Francisco-based Genentech fails to help patients live longer and causes life-threatening side effects ...
Related News:-
Dr. Manny Says: Patients, Families Will Suffer Most if FDA Yanks ...
In December, the Food and Drug Administration drafted a proposal to remove the approval of Avastin for breast cancer treatment. Now, tensions have hit a fever
Genetic Technologies Secures US Approval for Launch of BREVAGen ...
Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) has gained certification of its Australian laboratory under the US Clinical Laboratories...
FDA News - FDA History - Ultimate News Database
FDA News FDA History ... 11/05/2011 [-] FDA Approves Anticlotting Drug 11/05/2011 [-] FDA frozen oyster recall after norovirus cases
Hanes® Launches Comfort-Sharing Facebook Application for Breast ...
Hanes® today announced a new Facebook application to share comfort with those who need it most. Fans of Hanes on Facebook can...
www.tcrp.in
DCGI's consulting DTAB for banning controversial drugs may only help delay decision: Experts 2010-01-19: Union govt earmarks Rs.450 cr for 2 bio-cluster projects in NCR, Bangalore
Advocates crow as Blue Shield yanks rate hike - Political Blotter ...
Pages. About Political Blotter; Links to elected officials; Subscribe. Entries (RSS) Recent Posts. Voters surprisingly amenable to taxes; What the Sheriff’s office said about ...
Novartis Corporation News | SourceSolution's Biotech, Pharma, CMO ...
Article Date Source; Novartis Makes Donation to Cystic Fibrosis Worldwide to Support...--PRWeb - Pharmaceuticals: Novartis net profit rises 12% on sales gain of 27%
Topic Galleries -- baltimoresun.com
Topic galleries provide easy access to stories and photos about people, places, organizations, events and subjects of interest to you. They bring together rich multimedia ...
Enbrel
Enbrel This page contains recent news articles, when available, and an overview of Enbrel but does not offer medical advice. You should contact your physician with regard to ...
No comments:
Post a Comment